Announcements Trials
Browse Landscape

Phase

Phase 1 2Phase NA 1Phase 3 1Phase 2 1

Status

Unknown 3Completed 2

Sponsor Class

OTHER 41INDUSTRY 5OTHER_GOV 2

Study Type

Interventional 5

Sponsor

Cancer Type

Gastrointestinal 5

Conditions

Neoplasms 2870Carcinoma, Non-Small-Cell Lung 2420Breast Neoplasms 2065Colorectal Neoplasms 1239Neoplasm Metastasis 1223Prostatic Neoplasms 1076Melanoma 972Multiple Myeloma 960Ovarian Neoplasms 899Recurrence 849Leukemia, Myeloid, Acute 807Lung Neoplasms 756Pancreatic Neoplasms 750Lymphoma, Non-Hodgkin 726Lymphoma 660Stomach Neoplasms 622Carcinoma, Hepatocellular 564Carcinoma, Renal Cell 544Squamous Cell Carcinoma of Head and Neck 525Leukemia, Lymphocytic, Chronic, B-Cell 493Lymphoma, Follicular 468Head and Neck Neoplasms 449Glioblastoma 435Advanced Solid Tumors 430Small Cell Lung Carcinoma 408Triple Negative Breast Neoplasms 407Lymphoma, Large B-Cell, Diffuse 398Leukemia 394Uterine Cervical Neoplasms 367Advanced Solid Tumor 349

Interventions

Paclitaxel 2vorolanib 1spartalizumab 1rucaparib 1relatlimab 1linrodostat 1camrelizumab 1Nivolumab 1Ipilimumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
INDUSTRY × Interventional × Advanced Gastric Cancer × Clear all
NCT03223376 2025-12-01

FRUTIGA

Hutchmed

Phase 3 Completed
703 enrolled
Gastrointestinal

Advanced Gastric Cancer

NCT02935634 2023-06-09

FRACTION-GC

Bristol-Myers Squibb

Phase 2 Completed
190 enrolled 25 charts
Gastrointestinal

Advanced Gastric Cancer

NCT04385641 2020-05-13

Study on the Safety and Effectiveness of UCB-NK Cell Infusion in the Treatment of Advanced Gastric Cancer and Gastroesophageal Cancer

Shandong Golden Brick Biotechnology Co., Ltd.

Phase NA Unknown
18 enrolled
Gastrointestinal

Advanced Gastric Cancer

NCT03393416 2019-08-29

A Phase I Clinical Study for Evaluating the Safety of MASCT-I in Advanced Soild Tumor

HRYZ Biotech Co.

Phase 1 Unknown
28 enrolled
Gastrointestinal

Advanced Gastric Cancer

NCT03286244 2019-02-21

Second-line CM082 Combined With Paclitaxel For Patients With Advanced Gastric Cancer

AnewPharma

Phase 1 Unknown
21 enrolled
Gastrointestinal

Advanced Gastric Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡